









Markets
/
Stocks
/
nasdaq-cvs
/

CVS Health Corp

CVS

74.440USD

+0.410+0.55%

Close 01/29, 16:00（ET）Quotes delayed by 15 min

94.54BMarket Cap

198.08P/E TTM



CVS Health Corp

74.440

+0.410+0.55%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of CVS Health Corp

Currency: USD Updated: 2026-01-29

Key Insights

CVS Health Corp's fundamentals are relatively stable, and its growth potential is significant.Its valuation is considered fairly valued, ranking 48 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 93.79.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

CVS Health Corp's Score

Industry at a Glance

Industry Ranking

48 / 75

Overall Ranking

220 / 4540

Industry

Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

CVS Health Corp Highlights

StrengthsRisks

CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, PDPs and Medicaid health care management services. The Health Services segment provides a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home, and offers provider enablement solutions. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells an assortment of health and wellness products and general merchandise.

Industry Leader

The company's revenue leads the industry, with the latest annual revenue totaling USD 372.81B.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 15.61% year-on-year.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 73.28%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 73.28%.

Overvalued

The company’s latest PE is 198.08, at a high 3-year percentile range.

Institutional Buying

The latest institutional holdings are 1.14B shares, increasing 0.02% quarter-over-quarter.

Held by HACAX

Star Investor HACAX holds 347.00 shares of this stock.

Analyst Rating

Based on 29 analysts

Buy

Current Rating

93.786

Target Price

+30.26%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-01-29

The current financial score of CVS Health Corp is 5.42, ranking 70 out of 75 in the Healthcare Providers & Services industry. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 102.87B, representing a year-over-year increase of 7.80%, while its net profit experienced a year-over-year increase of 4668.97%.

Score

Industry at a Glance

Previous score

5.42

Change



Financials

4.86

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

Relevant data have not been disclosed by the company yet.



Quality of Earnings

6.86

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

Relevant data have not been disclosed by the company yet.



Operational Efficiency

4.87

Key Metrics

Cash flow from operating activities

Income after tax

Relevant data have not been disclosed by the company yet.



Growth Potential

4.00

Key Metrics

Cash flow from operating activities

Total revenue

Relevant data have not been disclosed by the company yet.



Shareholder Returns

6.51

Key Metrics

Free cash flow

Relevant data have not been disclosed by the company yet.

CVS Health Corp's Company Valuation

Currency: USD Updated: 2026-01-29

The current valuation score of CVS Health Corp is 8.55, ranking 8 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is 198.08, which is 12.67% below the recent high of 223.18 and 95.26% above the recent low of 9.39.

Score

Industry at a Glance

Previous score

8.55

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 48/75

Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-01-29

The current earnings forecast score of CVS Health Corp is 8.00, ranking 28 out of 75 in the Healthcare Providers & Services industry. The average price target is 93.00, with a high of 102.00 and a low of 79.00.

Score

Industry at a Glance

Previous score

8.00

Change

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 29 analysts

Buy

Current Rating

93.786

Target Price

+30.26%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

CVS Health Corp

CVS

Teladoc Health Inc

TDOC

HCA Healthcare Inc

HCA

Tenet Healthcare Corp

THC

Universal Health Services Inc

UHS

Privia Health Group Inc

PRVA

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-01-29

The current price momentum score of CVS Health Corp is 7.08, ranking 25 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 82.06 and the support level at 68.75, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.00

Change

0.08

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(4)

Neutral(2)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-1.667

Neutral

RSI(14)

39.343

Neutral

STOCH(KDJ)(9,3,3)

33.333

Sell

ATR(14)

2.856

High Vlolatility

CCI(14)

-136.640

Sell

Williams %R

71.826

Sell

TRIX(12,20)

-0.002

Sell

StochRSI(14)

21.207

Buy

Moving Average

Sell(5)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MA5

77.470

Sell

MA10

79.157

Sell

MA20

79.662

Sell

MA50

78.825

Sell

MA100

78.246

Sell

MA200

72.018

Buy

Institutional Confidence

Currency: USD Updated: 2026-01-29

The current institutional shareholding score of CVS Health Corp is 10.00, ranking 1 out of 75 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 91.37%, representing a quarter-over-quarter decrease of 0.35%. The largest institutional shareholder is The Vanguard, holding a total of 118.25M shares, representing 9.31% of shares outstanding, with 0.09% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

118.25M

-1.28%

Dodge & Cox

Star Investors

73.18M

-0.15%

Capital World Investors

68.38M

+2.12%

BlackRock Institutional Trust Company, N.A.

64.32M

+1.20%

State Street Investment Management (US)

58.94M

+0.25%

Fidelity Management & Research Company LLC

35.39M

-5.85%

Geode Capital Management, L.L.C.

28.99M

+1.23%

Capital International Investors

26.69M

+1.15%

Norges Bank Investment Management (NBIM)

19.70M

+5.31%

BlackRock Investment Management, LLC

16.94M

+5.62%

Risk Assessment

Currency: USD Updated: 2026-01-29

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. No risk assessment score is currently available for CVS Health Corp. The Healthcare Providers & Services industry's average is 5.62. The company's beta value is 0.50. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.